Funder
Brain and Behavior Research Foundation
New York Stem Cell Foundation
U.S. Department of Health & Human Services | National Institutes of Health
Publisher
Springer Science and Business Media LLC
Reference83 articles.
1. Ching, M. S. L. et al. Deletions of NRXN1 (neurexin-1) predispose to a wide spectrum of developmental disorders. Am. J. Med. Genet. B 153, 937–947 (2010).
2. Marshall, C. R. et al. Contribution of copy number variants to schizophrenia from a genome-wide study of 41,321 subjects. Nat. Genet. 49, 27–35 (2017).
3. Matsunami, N. et al. Identification of rare recurrent copy number variants in high-risk autism families and their prevalence in a large ASD population. PLoS ONE 8, e52239 (2013).
4. Moller, R. S. et al. Exon-disrupting deletions of NRXN1 in idiopathic generalized epilepsy. Epilepsia 54, 256–264 (2013).
5. Lowther, C. et al. Molecular characterization of NRXN1 deletions from 19,263 clinical microarray cases identifies exons important for neurodevelopmental disease expression. Genet. Med. 19, 53–61 (2017).
Cited by
97 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献